Hybrid and vaccine‐induced immunity against SAR‐CoV ‐2 in MS patients on different disease‐modifying therapies

Author:

Kister Ilya1ORCID,Curtin Ryan2,Pei Jinglan3,Perdomo Katherine1,Bacon Tamar E.1,Voloshyna Iryna2,Kim Joseph2,Tardio Ethan2,Velmurugu Yogambigai2,Nyovanie Samantha2,Valeria Calderon Andrea2,Dibba Fatoumatta2,Stanzin Igda2,Samanovic Marie I.4,Raut Pranil3,Raposo Catarina5,Priest Jessica3,Cabatingan Mark3,Winger Ryan C.3,Mulligan Mark J.4,Patskovsky Yury2,Silverman Gregg J.6,Krogsgaard Michelle2

Affiliation:

1. NYU Multiple Sclerosis Comprehensive Care Center, Department of Neurology New York University Grossman School of Medicine New York New York 10016 USA

2. Laura and Isaac Perlmutter Cancer Center and Department of Pathology New York University Grossman School of Medicine New York New York 10016 USA

3. Genentech, Inc. South San Francisco California USA

4. NYU Langone Vaccine Center, Department of Medicine NYU Grossman School of Medicine New York New York USA

5. F. Hoffmann‐La Roche Ltd Basel Switzerland

6. Division of Rheumatology, Department of Medicine New York University Grossman School of Medicine New York New York 10016 USA

Funder

Genentech

Publisher

Wiley

Subject

Neurology (clinical),General Neuroscience

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3